Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Atypical Hyperplasia|Breast Carcinoma|Breast Ductal Carcinoma In Situ|Breast Lobular Carcinoma In Situ
Interventions: DRUG: Acolbifene Hydrochloride|PROCEDURE: Biospecimen Collection|PROCEDURE: Mammography|PROCEDURE: Random Periareolar Fine-Needle Aspiration|DRUG: Tamoxifen
Sponsor: National Cancer Institute (NCI)